Improving quality of life in cancer patients through higher participation and health literacy: study protocol for evaluating the oncological social care project (OSCAR) by Frick, Johann et al.
STUDY PROTOCOL Open Access
Improving quality of life in cancer patients
through higher participation and health
literacy: study protocol for evaluating the
oncological social care project (OSCAR)
Johann Frick1* , Daniel Schindel1, Pimrapat Gebert1,2,3, Ulrike Grittner2,3 and Liane Schenk1
Abstract
Background: Cancer patients experience psychological and social distress due to their medical treatment and social
issues. However, continuous and specialized social support is still lacking. In Germany, a group of company
health insurance funds has developed an approach to support cancer patients with monthly structured interviews
conducted by specially trained Social Care Nurses. The nurses will identify patient needs in order to provide help with
medical, personal, and social matters. One aim of the scientific evaluation is to analyze the effect of the consultations
on various patient-reported outcomes, especially quality of life. The evaluation concept will be described in this study
protocol.
Methods/design: The evaluation is a non-randomized, controlled, multi-center intervention study with a mixed-method
design. It consists of three research modules which include primary data from questionnaires, and claims data from the
health insurance funds. In Module 1, cancer patients will be recruited to form an intervention group (OSCAR, n = 150)
and a control group (n = 200) in four study centers for a period of 1 year. One baseline and three follow-up
questionnaires will be conducted to survey the patient-reported outcomes. Relevant secondary outcomes are
health literacy, participation, and physician-patient communication. In Module 2, claims data will be used to
analyze cost effects and thereby assess effectivity and hospitalization. Module 3 will involve a qualitative analysis of project
diaries kept by the Social Care Nurses. The diaries will record the nurses’ practical experiences and the benefits of
deploying OSCAR across the German healthcare system.
Discussion: OSCAR is an innovative way of providing cancer patients with continuous support to improve their
quality of life. The evaluation concept aims to assess the effects of the monthly consultations by the Social Care
Nurses on the patients, and will use a mixed-method design. The results are important for assessing the transferability
of OSCAR to the healthcare system as a whole.
Trial registration: German Clinical Trials Register (DRKS-ID: DRKS00013640). Registered 29 December 2017.
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Background
Demand for social support for cancer patients
Cancer cause a high number of incident cases in
Germany every year (229,920 women and 252,550 men
in 2013) [1]. Due to the progression of the diseases,
patients and their relatives experience distress caused by
medical treatment and social issues [2, 3]. The misun-
derstanding of the disease can lead to inappropriate self-
assessments of one’s prognosis and a choice of unsuit-
able medical treatments [4]. Simultaneously, patients re-
ceive overtreatment even though they have an incurable
disease [5]. In these situations, palliative care could be
appropriate for improving quality of live [6]. Enhancing
palliative care can help patients to find suitable medical
treatments that can increase quality of life. However, the
specific needs of cancer patients are not taken into ad-
equate account by the healthcare system because of a
lack of palliative care [7]. Currently, patient navigation
programs are used to help patients with medical, nursing,
psychological, and healthcare-related issues. Recent stud-
ies have attempted to evaluate the impact of these pro-
grams (such as Onkolotse by the Saxon Cancer Society) [8,
9]. In this context, patient-reported outcomes (PROs) are
very important for examining the subjective benefit of in-
terventions from the patient’s perspective, with the focus
on relevant outcomes (e.g. quality of life) [10].
Development of the OSCAR project
The Oncological Social Care Project (OSCAR) was de-
veloped by the German company health insurance fund
Pronova BKK. The concept is based on the Saxon Can-
cer Society’s Onkolotse navigation program for cancer
patients. An essential component of OSCAR is the
additional social support provided by the Social Care
Nurses (SCNs), who aim to identify deficits in healthcare
utilization by cancer patients and support them in
relevant areas (e.g. the medical treatment of the cancer,
psychosocial support for anxiety, practical tips regarding
social security services, and organization of rehabilita-
tion). Moreover, the SCNs are regular and accessible
contact partners in a complex and fragmented multidis-
ciplinary treatment process. Each patient is accompanied
for 1 year, regardless of whether they are being treated
as inpatients or outpatients, or are currently not receiv-
ing any therapy. The intervention aims to access and
improve the quality of life for patients with advanced
cancer and a poor prognosis. It uses twelve structured
interviews over the course of 1 year. The SCNs received
training from the Saxon Cancer Society. OSCAR is im-
plemented by five SCNs at four locations.
Methods
The OSCAR evaluation is a mixed-method study consisting
of three research modules. Modules 1 and 2 involve a non-
randomized, controlled, multi-center intervention study
which compares primary data from regularly conducted
questionnaires and claims data from German statutory
health insurance funds in the intervention and control
groups. In addition, a qualitative content analysis is planned
in module 3 and will be based on the project diaries com-
pleted by each SCN. The analysis will assess OSCAR’s ef-
fectivity and the benefit of implementing it in the German
healthcare system (Fig. 1).
Study objectives
Primary objective:
To compare quality of life over study period between
the intervention group (patients who had met an SCN)
and the control group (Module 1).
Secondary objective:
1. To compare the health literacy, participation, and
physician-patient communication in the
intervention and control groups (Module 1)
2. To explore the associations between quality of life
and health literacy, participation, and
physician-patient communication (Module 1)
3. To compare the incidence rate of outpatient visits
in both groups (Modules 1 and 2)
4. To compare the healthcare costs in both groups
(Module 2)
5. To assess the SCN’s practical experiences (Module
3)
Inclusion and exclusion criteria for participation in the
evaluation survey in modules 1 and 2
Inclusion criteria:
 Aged ≥18 years
 At least a combination of one type of cancer and
one operation and procedure, as defined by the ICD




Module 1: primary data, patient-reported outcomes
Participant recruitment
The recruitment was carried out in four different hospitals
with oncology departments across three cities in two states
in Germany. Two of the hospitals are located in Berlin,
while the other two are in Leverkusen and Duisburg.
In all four study sites, the SCNs recruited BKK-
insured patients for the intervention group by obtaining
informed consent. The SCNs are responsible for the
monthly consultations to support the patients in the
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intervention group. Patients who are insured with a dif-
ferent provider were recruited by Study Nurses (SNs) for
the control group. The SNs’ main task is to conduct the
evaluation questionnaires in both study groups up to
four times within 1 year. The evaluation’s baseline sur-
vey will be conducted after recruitment (t0) and followed
up after 90 (t1), 180 (t2), and 365 (t3) days. The patients
can choose between personal, telephone, and postal
interviews, depending on their health status and which
method is most comfortable for them. Dividing respon-
sibilities between SCNs and SNs is necessary to ensure
the independence of the evaluation surveys. Patients in
both groups were recruited at the same study sites
between February 2018 and the end of February 2019.
Questionnaire
The items for the evaluation questionnaire are listed in
Table 1:
Further instruments are used to measure sociodemo-
graphic variables, especially with regard to age, sex, migra-
tion status, and social status [19–21]. Finally, participants
in the intervention group will be asked to evaluate their
Fig. 1 Modules in the OSCAR evaluation concept
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contact with the SCN for the last 3 months. The items are
related to specific consultation topics and whether or not
the support was useful for the respective topic. Partici-
pants will also be asked about the quality and quantity of
contact with the SCN.
Statistics
Sample size calculation
A sample size of 100 participants in the intervention
group and 150 in the control group will reach a power
of 80% at a two-sided level of significance of 5% to de-
tect a difference in the EORTC QLQ-C30 (scores range
from 0 to 100) with a Cohen’s d effect size of 0.4 (mean
difference of ten scores and standard deviation (SD) of
25 scores) [11]. Given that the effect size might be
smaller due to a lower mean difference or higher SD,
and that the severity of cancer can cause higher dropout
rates, we aim to include 150 participants in the
intervention group and 200 in the control group (so a
total sample size of 350 participants).
The sample size calculation based on the t-test was used
in spite of the intended analysis with a baseline-adjusted
repeated-measures linear mixed model (ANCOVA, three-
level random intercept model to account for repeated
measures in patients and clustering in centers). It can be
shown [22] that a conservative approach for estimating
sample sizes has the same power as a t-test with n subjects
where p is the variance deflation factor, calculated by the
correlation of baseline and follow-up measures. Assuming
the worst case of p = 0 leads to the sample size based on
the t-test.
Statistical analysis plan
All statistical tests are performed using Stata IC15 (Sta-
taCorp, 2017, College Station, TX, USA). The primary
hypothesis will be tested at a two-sided significance level
Table 1 Items in the evaluation questionnaire
Item Description
Quality of Life of Cancer Patients (EORTC QLQ-
C30) [11]
The EORTC QLQ-C30 is a questionnaire for measuring health-related quality of life, and is provided
by the European Organisation for Research and Treatment of Cancer. Patients are asked to answer
30 questions, which address e.g. physical, emotional, cognitive, and social issues. 28 items have
four response options. Two items for the global health status and the quality of life have a seven-
point scale. The EORTC QLQ-C30 consists of five functional scales and three symptom scales. In
addition, a global health status (QoL) scale as well as six single items. All of the scales and the sin-
gle items will use a linear transformation to standardize the raw score. The scores range from 0
to 100.
Illness Perception Questionnaire (IPQ) [12] The IPQ consists of 64 items on 8 scales, and measures the individual’s beliefs and feeling about
their illness. The illness coherence subscale consists of five items and is used for the evaluation
questionnaire in this study. The scores will be summed and divided by the number of items.
Patient Reaction Assessment (PRA-D) [13] The PRA-D is a self-description instrument to record the patient-perceived quality of the relation-
ship between patients and physicians. In this study, we adapted five communication questions to
a five-point Likert scale (from 1 = “I strongly disagree” to 5 = “I strongly agree”).
German modified version of the Autonomy
Preference Index (API-Dm) [14]
The API-Dm measures patients’ preferences for participation and information regarding medical
decisions. Patients are asked to answer eleven questions using a four-point Likert scale (from
0 = “strongly disagree” to 4 = “strongly agree”). The information preference consists of seven items,
with scores ranging from 0 to 28. The participation preference consists of four items, with scores
ranging from 0 to 16. The total score of each patients’ preference will be transformed into scores
ranging from 0 to 100.
Decisional Conflict Scale (DCS-10) [15] The DCS-10 is a self-reported questionnaire, which allows an evaluation of decision conflicts
among patients. The short version of the DSC comprises ten items grouped into four subscales:
uncertainty, information, values clarity, and support decision. Each item is measured on a three-
point Likert scale (0 = “yes”, 2 = “unsure”, 4 = “no”). Scores range from 0 (no decision conflict) to
100 (extremely high decision conflict).
European Health Literacy Survey (HLS-EU-Q6)
[16]
The HLS-EU-Q6 is the short version of the 47-question European Health Literacy Survey. It is di-
vided into three areas: healthcare, disease prevention, and health promotion. Each of the six ques-
tions has five possible responses. A mean score is calculated and allocated to one of three
categories: insufficient health literacy (range 1–2), problematic health literacy (2–3), and sufficient
health literacy (3–4).
Medical Care Utilization [17] Medical care will be assessed by the frequency of utilization of different therapies and physician
groups.
Oslo Social Support Scale (OSSS-3) [18] The OSSS-3 is a brief measurement of social support. It consists of three questions that address
the number of close people, interest and concern from other people, and practical help from
neighbors. The scores range from 3 to 14 and will be categorized into three groups: 3–8 indicates
poor support, 9–11 shows moderate support, and 12–14 reflects strong support.
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of α = 0.05. All secondary hypotheses will be tested
within an exploratory framework.
Descriptive statistics and the number of participants
reflected in the calculation (n) will be presented in each
group. For continuous variables, mean with SD for nor-
mal distribution and median with interquartile range
(IQR) for other distribution variables will be presented.
For categorical data, frequencies and percentages will be
displayed for each category. Graphic methods such as
box plots and line graphs will be used for visualizing the
data.
The comparison of EORTC QLQ-C30 (global health
status as a primary outcome), physician-patient commu-
nication (scores), health competence (scores), participa-
tion (scores), and knowledge (scores) over the study
period between the groups will be reported as mean and
95% CI, and performed using a linear mixed model
(LMM) with three levels over all available time points.
Random intercepts for the patient ID and for the study
clinics are included in the model to account for the
cluster structure of the data. To keep selection bias to a
minimum, we will develop a propensity score for
adjusting baseline factors. The propensity score will be
used with the inverse probability of treatment weight-
ing (IPTW) method because the results from this
method are similar to a randomized trial [23, 24].
The number of outpatient visits will be counted and
the study time will be calculated over the follow-up time
for each patient. The incidence rate of outpatient visits
per person-time will be presented, and Poisson regres-
sion will be used to compare the incidence rate between
groups.
All outcomes will be analyzed using modified intent-
to-treat populations including all subjects who receive at
least one consultation from an SCN and for whom at
least the first follow-up assessment at Visit 1 (at 3
months) is available.
Dropouts and missing data
Reasons for dropouts will be documented and reported.
If patients are alive and missings are assumed to be
missing at random (MAR), we will use multiple imput-
ation methods based on ten imputed data sets [25] with
multiple imputation by chained equations (MICE).
Module 2: secondary data, claims data from health
insurance funds
Design and participants
Another part of the OSCAR evaluation involves analyz-
ing claims data from the BKK health insurance funds. In
contrast to the patient-reported parameters in Module 1,
the claims data will make it possible to analyze objective
parameters. This kind of data is a valid and relevant
source, and has been used in many healthcare research
projects in Germany. The data from Modules 1 and 2
will not be linked. If available, the secondary data will be
analyzed for the period up to 12 months before and after
enrollment.
Inclusion and exclusion criteria
This data is only available for the patients in the inter-
vention group, who have health insurance with BKK
(n = 150). A new, independent and anonymous control
group will therefore be drawn from BKK-insured pa-
tients who did not take part in the OSCAR intervention
(n = 600). All included patients must meet the inclusion
and exclusion criteria mentioned above. Furthermore,
the patients in the control group should be treated in
hospitals comparable to those where the patients in the
intervention group were treated. In addition, the control
group will be matched with the intervention group by
age, gender, and diagnosis.
Variables
The following aspects are of interest: time-to-death, all
costs of treatment, and the incidence rate of hospitalization
and outpatient visits.
Statistical analysis plan
Paired t-test or Wilcoxon signed rank test will be per-
formed to compare the costs of treatment per month.
The generalized estimating equation (GEE) for Poisson
regression will be applied to compare the incidence rate
of hospitalization and outpatient visits between interven-
tion and matched controls. Kaplan-Meier curve and Cox
regression analysis will be performed to compare time-
to-death between the groups.
Module 3: qualitative analyses of SCN project diaries
Design and participants
The qualitative analyses of project diaries provide import-
ant insights into the work of the SCNs. The nurses will be
asked to record their feedback concerning positive aspects
of the OSCAR program, as well as opportunities for
further improvements with regard to the transferability of
OSCAR to the regular healthcare system. For each patient,
the SCNs will record the number of additional consulta-
tions between two planned monthly consultations, and any
recommendations to visit partners in their supply network.
Analysis plan
The following aspects are of interest for the qualitative
content analysis: acceptance of OSCAR among the
patients and among the participating hospitals; number
of additional consultations for patients; subjective feed-
back and reasons for early program termination by the
patient; barriers to consultations.
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Discussion
This study aims to evaluate whether the OSCAR program
can improve quality of life for patients with advanced can-
cers and a poor prognosis by enhancing health literacy
and participation in therapy planning through continued
supportive care from an SCN. A variety of approaches
currently exist for developing and evaluating navigation
programs for cancer patients. One example is the Onko-
lotse project from the Saxon Cancer Society. It involves
certified nurses, psychologists, and social workers, who
having contact with cancer patients about 20 times within
1 year. The evaluation of this project focuses on the num-
ber of hospital admissions and psychological stress [8].
Nurses from the non-profit association Group Health
contact patients weekly via telephone, and meet with them
face-to-face at least once [26]. The nurses aim to develop
strategies that address distress and focus on quality of life.
In another project, experienced nurses attempt to identify
patient needs with three different assessment tools and
personal conversations [27]. The endpoints in this study
are e.g. patient satisfaction, acceptance of the nurses’
advice, and the use of support services for cancer.
Nevertheless, there is a lack of implementation of
these approaches in Germany. OSCAR was developed to
provide patients with a year of regular support in matters
regarding their cancer. This is a useful addition to existing
structures such as the social services provided by hospi-
tals, which address the immediate needs of patients after
hospital discharge. Improving the continuity of care and
building patient competences are important for cancer pa-
tients in a fragmented healthcare system. Moreover, suit-
able healthcare structures and contract frameworks are
necessary for delivering low-threshold access to palliative
care and supporting consultations.
Experiences gathered with OSCAR could be trans-
ferred to other chronic somatic diseases which are asso-
ciated with severe physical and psychological distress in
patients and their relatives.
One advantage of the evaluation is the mixed-method
design, which includes patient-reported outcomes, claims
data from health insurance funds, and qualitative analyses
of the SCNs’ project diaries. To evaluate the effects of
continuous SCN support in Module 1, a prospective, non-
randomized, multicenter, longitudinal study design was
applied. Our patients were not assigned randomly, due to
the limitation of the SCNs, who were trained and sup-
ported by the BKK insurance fund. Since randomization
was not carried out, we are concerned about selection
bias. Therefore, the baseline characteristics will be com-
pared and we will control for baseline imbalance by using
propensity score in our analysis. The propensity score
with the inverse probability of treatment weighting
(IPTW) method will be applied because the results from
this method are similar to a randomized trial [23, 24]. For
Module 2, we will match the intervention and control
cases in order to reduce bias and confounding factors as
much as possible. Moreover, given the severity of the pa-
tients’ conditions, we aimed to reduce the interview time by
using the short versions of the instruments, if available,
rather than applying generic instruments. In conclusion, we
believe our study provides healthcare support for cancer
patients. Hopefully, it can be applied for other severe
chronic diseases. The evaluation of OSCAR is currently on-
going. In terms of providing healthcare support according
to the patient’s needs, we expect our study to show that
SCN support has a positive effect on the patient’s quality of
life, health literacy, and participation in therapy planning.
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